Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products.

Chen CH, Yang JC, Uang YS, Lin CJ.

Int J Pharm. 2013 Feb 28;444(1-2):18-24. doi: 10.1016/j.ijpharm.2013.01.028.

PMID:
23352857
2.

Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin.

Chen CH, Uang YS, Wang ST, Yang JC, Lin CJ.

Evid Based Complement Alternat Med. 2012;2012:127043. doi: 10.1155/2012/127043.

3.

Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques.

Patel M, Tekade A, Gattani S, Surana S.

AAPS PharmSciTech. 2008;9(4):1262-9. doi: 10.1208/s12249-008-9171-4.

4.

Redispersible, dry emulsion of lovastatin protects against intestinal metabolism and improves bioavailability.

Ge Z, Zhang XX, Gan L, Gan Y.

Acta Pharmacol Sin. 2008 Aug;29(8):990-7. doi: 10.1111/j.1745-7254.2008.00825.x.

5.

Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs.

Wu C, Wang Z, Zhi Z, Jiang T, Zhang J, Wang S.

Int J Pharm. 2011 Jan 17;403(1-2):162-9. doi: 10.1016/j.ijpharm.2010.09.040.

PMID:
20937370
6.

The interaction of diltiazem with lovastatin and pravastatin.

Azie NE, Brater DC, Becker PA, Jones DR, Hall SD.

Clin Pharmacol Ther. 1998 Oct;64(4):369-77.

PMID:
9797793
7.

Pharmacokinetics of lovastatin extended-release dosage form (Lovastatin XL) in healthy volunteers.

Lamson M, Phillips G, Shen J, Lukacsko P, Friedhoff L, Niecestro RM.

Biopharm Drug Dispos. 2002 May;23(4):143-9.

PMID:
12015788
8.

Preparation and characterization of solid dispersion of simvastatin.

Silva TD, Arantes VT, Resende JA, Speziali NL, de Oliveira RB, Vianna-Soares CD.

Drug Dev Ind Pharm. 2010 Nov;36(11):1348-55. doi: 10.3109/03639041003801901.

PMID:
20545512
9.

Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.

Zhou J, Zhou D.

Drug Des Devel Ther. 2015 Sep 18;9:5269-75. doi: 10.2147/DDDT.S90016.

10.
11.

Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin.

Choi DH, Chung JH, Choi JS.

Eur J Clin Pharmacol. 2010 Mar;66(3):285-90. doi: 10.1007/s00228-009-0757-x.

PMID:
20012601
12.

Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.

Jiang T, Han N, Zhao B, Xie Y, Wang S.

Drug Dev Ind Pharm. 2012 Oct;38(10):1230-9. doi: 10.3109/03639045.2011.645830.

PMID:
22229827
13.

Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.

Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.

J Pharm Pharm Sci. 2011;14(2):196-214.

14.

Effects of lovastatin on the pharmacokinetics of nicardipine in rats.

Chung JW, Yang SH, Choi JS.

Biopharm Drug Dispos. 2010 Oct;31(7):436-41. doi: 10.1002/bdd.721.

PMID:
20824619
15.

Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin.

Guo M, Fu Q, Wu C, Guo Z, Li M, Sun J, He Z, Yang L.

Colloids Surf B Biointerfaces. 2015 Apr 1;128:410-8. doi: 10.1016/j.colsurfb.2015.02.039.

PMID:
25766921
16.

Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin.

Pan HY, DeVault AR, Wang-Iverson D, Ivashkiv E, Swanson BN, Sugerman AA.

J Clin Pharmacol. 1990 Dec;30(12):1128-35.

PMID:
2125605
17.

Distribution of lovastatin to bone and its effect on bone turnover in rats.

Jadhav SB, Narayana Murthy PS, Singh MM, Jain GK.

J Pharm Pharmacol. 2006 Nov;58(11):1451-8.

PMID:
17132207
18.

Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers.

Reyderman L, Kosoglou T, Boutros T, Seiberling M, Statkevich P.

Curr Med Res Opin. 2004 Sep;20(9):1493-500.

PMID:
15383199
19.

Solid-state dependent dissolution and oral bioavailability of piroxicam in rats.

Lust A, Laidmäe I, Palo M, Meos A, Aaltonen J, Veski P, Heinämäki J, Kogermann K.

Eur J Pharm Sci. 2013 Jan 23;48(1-2):47-54. doi: 10.1016/j.ejps.2012.10.005.

PMID:
23085546
20.

Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers.

Mignini F, Tomassoni D, Streccioni V, Traini E, Amenta F.

Clin Exp Hypertens. 2008 Feb;30(2):95-108. doi: 10.1080/10641960801944249.

PMID:
18293165
Items per page

Supplemental Content

Support Center